SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-08-061865
Filing Date
2008-11-07
Accepted
2008-11-07 14:13:31
Documents
8
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 v130710_10q.htm 10-Q 1004002
2 GRAPHIC logo1.jpg GRAPHIC 32606
3 v130710_ex10-7.htm EX-10.7 78874
4 v130710_ex10-69.htm EX-10.69 100222
5 v130710_ex31-1.htm EX-31.1 18779
6 v130710_ex31-2.htm EX-31.2 18944
7 v130710_ex32-1.htm EX-32.1 7101
8 v130710_ex32-2.htm EX-32.2 8121
  Complete submission text file 0001144204-08-061865.txt   1282643
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 081170472
SIC: 2834 Pharmaceutical Preparations